Sujay Kango Biography and Net Worth

Mr. Kango joined Acceleron in February 2018 and brings over 25 years of commercial leadership and expertise in both biotechnology and large pharmaceutical companies. In late 2019, he established the Company’s North America commercial footprint in preparation for the launch of REBLOZYL® (luspatercept-aamt) and continues to lead the development of North America commercial capabilities and U.S. commercial operations. Throughout his career, he has led multiple global product launches, including Kyprolis® and Remicade®, built commercial teams, and also served in collaboration leadership roles for both the Onyx Pharmaceuticals-Bayer and Infinity Pharmaceuticals-AbbVie partnerships. Most recently at AbbVie, Mr. Kango served as the Vice President of Global Commercial Development for Oncology, prior to which he served as the Executive Vice President and Chief Commercial Officer at Infinity Pharmaceuticals. Mr. Kango also served as Vice President, Global Marketing, and Sales Operations at Onyx Pharmaceuticals, an Amgen subsidiary. Prior to Onyx, he held several leadership positions including Vice President Sales and Marketing-Oncology at Merck & Co., Global Commercial Leader-Procrit®/Eprex® at Ortho-Biotech, and various sales and marketing positions at Schering-Plough. Mr. Kango earned a B.S. in Microbiology and an M.B.A. from McNeese State University.